Publication: Oral health related quality of life and disease severity in autoimmune bullous diseases
| dc.contributor.authors | Bilgic, A.; Aydin, F.; Sumer, P.; Keskiner, I; Koc, S.; Bozkurt, S.; Mumcu, G.; Alpsoy, E.; Uzun, S.; Akman-Karakas, A. | |
| dc.date.accessioned | 2022-03-12T22:54:45Z | |
| dc.date.accessioned | 2026-01-11T06:52:34Z | |
| dc.date.available | 2022-03-12T22:54:45Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Background: There is an increased risk of long-term dental and periodontal disease in autoimmune bullous diseases (AIBD). Aims: In this cross-sectional study, we aimed to determine whether the oral health-related quality of life status (OHRQoL) was associated with disease severity and activity in patients with AIBD. Subjects and Methods: 67 patients with AIBD were enrolled in this study. Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) was used to evaluate the disease severity. The score was categorized as a significant course (>= 17) and moderate course (<17). Oral health impact profile-14 (OHIP-14) questionnaire was filled to assess the OHRQoL. Self-reported oral health status and oral lesion related pain score were also evaluated in the study group. Results: OHIP-14 score was significantly higher in active patients (42.28 +/- 13.66) than inactive patients (29.08 +/- 12.25) (P = 0.004) and it was correlated with the pain score (6.33 +/- 2.78; r = 0.409, P = 0.013). Furthermore, OHIP-14 score was higher in patients with a significant disease course (45.18 +/- 15.08) (P = 0.010) than in patients with a moderate course (36.09 +/- 9.73). Conclusions: OHRQoL may be useful in the disease management and treatment. Since it can be affected by both presence of oral erosions and disease severity, a collaboration between dermatologists and dentists could be crucial to the disease management in AIBD. | |
| dc.identifier.doi | 10.4103/njcp.njcp_216_19 | |
| dc.identifier.issn | 1119-3077 | |
| dc.identifier.pubmed | 32031089 | |
| dc.identifier.uri | https://hdl.handle.net/11424/236509 | |
| dc.identifier.wos | WOS:000514446300005 | |
| dc.language.iso | eng | |
| dc.publisher | WOLTERS KLUWER MEDKNOW PUBLICATIONS | |
| dc.relation.ispartof | NIGERIAN JOURNAL OF CLINICAL PRACTICE | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Autoimmune bullous diseases | |
| dc.subject | bullous pemphigoid | |
| dc.subject | health related quality of life | |
| dc.subject | oral health | |
| dc.subject | pemphigus vulgaris | |
| dc.subject | CENTERED OUTCOME MEASURES | |
| dc.subject | INTENSITY SCORE ABSIS | |
| dc.subject | PEMPHIGUS-VULGARIS | |
| dc.subject | PERIODONTAL STATUS | |
| dc.subject | TRIAMCINOLONE ACETONIDE | |
| dc.subject | BEHCETS-DISEASE | |
| dc.subject | MUCOSAL DISEASE | |
| dc.subject | LICHEN-PLANUS | |
| dc.subject | IMPACT | |
| dc.subject | RELIABILITY | |
| dc.title | Oral health related quality of life and disease severity in autoimmune bullous diseases | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 164 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | 159 | |
| oaire.citation.title | NIGERIAN JOURNAL OF CLINICAL PRACTICE | |
| oaire.citation.volume | 23 |
